CNXC vs. ALLE, STN, ICLR, RTO, CART, MEDP, HQY, BILI, WPP, and LYFT
Should you be buying Concentrix stock or one of its competitors? The main competitors of Concentrix include Allegion (ALLE), Stantec (STN), Icon (ICLR), Rentokil Initial (RTO), Maplebear (CART), Medpace (MEDP), HealthEquity (HQY), Bilibili (BILI), WPP (WPP), and Lyft (LYFT). These companies are all part of the "business services" industry.
Concentrix vs. Its Competitors
Concentrix (NASDAQ:CNXC) and Allegion (NYSE:ALLE) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.
Allegion has a net margin of 16.28% compared to Concentrix's net margin of 2.54%. Allegion's return on equity of 44.82% beat Concentrix's return on equity.
Concentrix presently has a consensus target price of $66.75, suggesting a potential upside of 18.14%. Allegion has a consensus target price of $145.33, suggesting a potential downside of 1.87%. Given Concentrix's stronger consensus rating and higher probable upside, analysts clearly believe Concentrix is more favorable than Allegion.
Concentrix pays an annual dividend of $1.33 per share and has a dividend yield of 2.4%. Allegion pays an annual dividend of $2.04 per share and has a dividend yield of 1.4%. Concentrix pays out 36.5% of its earnings in the form of a dividend. Allegion pays out 28.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Concentrix has increased its dividend for 3 consecutive years and Allegion has increased its dividend for 11 consecutive years.
Allegion has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Allegion, indicating that it is currently the more affordable of the two stocks.
In the previous week, Concentrix had 21 more articles in the media than Allegion. MarketBeat recorded 28 mentions for Concentrix and 7 mentions for Allegion. Allegion's average media sentiment score of 1.20 beat Concentrix's score of 0.40 indicating that Allegion is being referred to more favorably in the news media.
Concentrix has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Comparatively, Allegion has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.
90.3% of Concentrix shares are owned by institutional investors. Comparatively, 92.2% of Allegion shares are owned by institutional investors. 3.2% of Concentrix shares are owned by insiders. Comparatively, 0.2% of Allegion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Allegion beats Concentrix on 12 of the 20 factors compared between the two stocks.
Get Concentrix News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNXC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CNXC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Concentrix Competitors List
Related Companies and Tools
This page (NASDAQ:CNXC) was last updated on 7/3/2025 by MarketBeat.com Staff
